Table 3.
QTc prolongation | TdP risk | |
---|---|---|
Chloroquine37–40 | Moderate ↑ | Low risk of TdP |
Hydroxychloroquine41 | Moderate ↑ | Low risk of TdP |
Azithromycin42–48 | Moderate ↑ | Very low risk of TdP |
Lopinavir/ritonavir37 | Moderate ↑ | Low risk of TdP |
Tocilizumab49 | Mild ↑ or ↓ | NR |
Fingolimod | Mild ↑ | NR |
Remdesivir | NR | NR |
Interferon alfacon-1 | NR | NR |
Ribavirin | NR | NR |
Methylprednisolone | NR | NR |
NR, not reported; TdP, torsade de pointes.